Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)
- DOI
- 10.1097/coc.0000000000000099
- Published
- 2016-12
- Container
- American Journal of Clinical Oncology
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/coc.0000000000000099,
title = {Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)},
author = {Francis A.S. Lee and Benny Chung-Ying Zee and Foon Yiu Cheung and Philip Kwong and Chi Leung Chiang and Kwong Chuen Leung and Steven W.K. Siu and Conrad Lee and Maria Lai and Chloe Kwok and Marc Chong and Jacques Jolivet and Steward Tung},
year = {2016},
journal = {American Journal of Clinical Oncology},
doi = {10.1097/coc.0000000000000099},
url = {https://doi.org/10.1097/coc.0000000000000099}
}RIS
TY - JOUR TI - Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) AU - Francis A.S. Lee AU - Benny Chung-Ying Zee AU - Foon Yiu Cheung AU - Philip Kwong AU - Chi Leung Chiang AU - Kwong Chuen Leung AU - Steven W.K. Siu AU - Conrad Lee AU - Maria Lai AU - Chloe Kwok AU - Marc Chong AU - Jacques Jolivet AU - Steward Tung PY - 2016 JO - American Journal of Clinical Oncology DO - 10.1097/coc.0000000000000099 UR - https://doi.org/10.1097/coc.0000000000000099 ER -
APA
Lee, F. A., Zee, B. C., Cheung, F. Y., Kwong, P., Chiang, C. L., Leung, K. C., Siu, S. W., Lee, C., Lai, M., Kwok, C., Chong, M., Jolivet, J., & Tung, S. (2016). Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC). American Journal of Clinical Oncology. https://doi.org/10.1097/coc.0000000000000099
Source records
- crossref · retrieved 2026-09-26T22:37:26.137Z